Bio-Works Technologies AB Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Lone Poulsen Carlbom, was filed 27 Aug 2025.
Who traded when
BuySaleTransparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 300,000 shares@ SEK 3.21100.0% of flowTerminerISIN SE0007387089FI:A003R723-2Canonical exit: 23 Nov 2025 (T+90)
- 64,440 shares@ SEK 2.670.053% mcap100.0% of flowAktieISIN SE0007387089FI:A003R577-1Canonical exit: 16 Nov 2025 (T+90)
- 2,200 shares@ SEK 2.880.0020% mcap4.0% of flowAktieISIN SE0007387089FI:A003R578-1Canonical exit: 17 Nov 2025 (T+90)
- 100,000 shares@ SEK 1.490.047% mcap96.0% of flowAktieISIN SE0007387089FI:A003O874-1Canonical exit: 20 Aug 2025 (T+90)
- 342,241 shares@ SEK 1.520.17% mcap100.0% of flowAktieISIN SE0007387089FI:A003O876-1Canonical exit: 20 Aug 2025 (T+90)
- 15,600 shares@ SEK 11.62100.0% of flowAktieFI:A001S185-1
- 15,600 shares@ SEK 11.62100.0% of flowBTU (betald tecknad unit)ISIN SE0009522337FI:A001S148-1
- 7,500 shares@ SEK 13.00100.0% of flowAktieISIN SE0007387089FI:A001R032-1Canonical exit: 3 Jun 2021 (T+90)
- 100,000 shares@ SEK 8.5043.1% of flowAktieISIN SE0007387089FI:csv-b56469aec9911c974f0d
- 2,200 shares@ SEK 8.621.0% of flowAktieISIN SE0007387089FI:csv-7288b19aaebc7a7bd69e
- 1,000 shares@ SEK 8.969.4% of flowAktieISIN SE0007387089FI:csv-a82c0554c9708509f62eCanonical exit: 22 Nov 2020 (T+90)
- 200,000 shares@ SEK 1.1669.8% of flowWarrantISIN SE0007387089FI:csv-ba7f609779cbe188ae1d
- 40,000 shares@ SEK 1.169.2% of flowOptionISIN SE0007387089FI:csv-93fc2c02d60d44f8eb8b
- 50,000 shares@ SEK 1.1660.1% of flowTeckningsoptionISIN SE0007387089FI:csv-1a10f01c4f2a02dd6dba
- 22,000 shares@ SEK 7.2014.3% of flowAktieISIN SE0007387089FI:csv-4edb465539291529b1fd
- 2,000 shares@ SEK 7.5414.7% of flowAktieISIN SE0007387089FI:csv-e3533f5a50c01a7f1e85Canonical exit: 3 Aug 2020 (T+90)
- 5,000 shares@ SEK 7.8816.9% of flowAktieFI:csv-589a29cca659ba86a662Canonical exit: 29 Jul 2020 (T+90)
- 1,430 shares@ SEK 8.082.3% of flowAktieISIN SE0007387089FI:csv-0ba5535287100aabc7d1Canonical exit: 18 May 2020 (T+90)
- 5,072 shares@ SEK 8.088.1% of flowAktieISIN SE0007387089FI:csv-70af27b888b99a28d4c7Canonical exit: 18 May 2020 (T+90)
- 40,000 shares@ SEK 7.9216.1% of flowAktieISIN SE0007387089FI:csv-24ab8a8886239eff051c
- 10,000 shares@ SEK 7.8274.0% of flowAktieISIN SE0007387089FI:csv-8ae5fe979dbaa1b949b7
- 10,000 shares@ SEK 7.8922.5% of flowAktieISIN SE0007387089FI:csv-deb35b7fcdb29edd531cCanonical exit: 17 May 2020 (T+90)
- 549,612 shares@ SEK 6.3050.2% of flowAktieISIN SE0007387089FI:csv-c37d5b4ed863bda9bf0e
- 2 shares0TeckningsrättFI:csv-563eb115e76490945688
- 4,428 shares@ SEK 6.305.5% of flowBTA (betald tecknad aktie)ISIN SE0012703072FI:csv-993aa427c10cfea322ac
25 of 63 declarations
About Bio-Works Technologies AB
Bio-Works Technologies AB has seen two periods: 2019, with 32 of the 63 filings, and 2025, with 5. The most recent purchases are also the largest: EUR 86,386 for Lone Poulsen Carlbom (Verkställande direktör, VD) on August 25, 2025, EUR 47,823 for Carl Jonas Ahlen (Styrelseledamot) on May 22, 2025 and EUR 15,418 for AB Bonit Invest on August 18, 2025. In all, 25 purchases come to EUR 253,697, with a median of EUR 4,252.
The sales are older and come mostly from Jan Berglöf (Medlem av ledningsgruppen, management team member), who lodges 15 filings, all sales: EUR 80,696 on September 29, 2020, EUR 30,163 on February 18, 2020 and EUR 16,248 on February 25, 2019. The 20 sales, 17 of them with an amount, come to EUR 192,425, so purchases make up 56% of open-market trades.
Read moreShow less
From May 27 to June 25, 2019, 5 insiders bought within the same window for EUR 35,265. The Swedish technology company, listed in Stockholm, is worth SEK 307,266,464, of which 50.9% is held by insiders. No filing falls within the last twelve months. For 25 purchases the stored 90-day median is 9.1%, with 64% positive: a record of the past, not a forecast.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
